66 results about "Cough variant asthma" patented technology

The invention provides a traditional Chinese medicine granular suspension preparation for treating cough post influenza and cough variant asthma and a preparation method thereof. The traditional Chinese medicine granular suspension preparation comprises medicinal effective ingredients and pharmaceutically applicable medicinal adjuvants, wherein the medicinal effective ingredients are prepared from the following raw medicines in parts by weight by the conventional method: 4 to 6 parts of fried ephedra, 4 to 6 parts of folia perillae acutae, 4 to 6 parts of lumbricus, 4 to 6 parts of fried folium eriobotryae, 2 to 4 parts of perillaseed, 3 to 5 parts of periostracum cicada, 3 to 5 parts of radix peucedani, 4 to 6 parts of fructus arctii, and 3 to 5 parts of schisandra chinensis; the pharmaceutically applicable medicinal adjuvants include a filling agent, a diluent, an adhesive, a solubilizer, a cosolvent, an adsorbent and a corrigent. The traditional Chinese medicine granular suspension preparation integrates the advantages of liquid preparations and solid preparations, is quickly absorbed and fast to act after being orally taken, and is high in bioavailability, and convenient to carry and transport.

The invention belongs to the field of traditional Chinese medicines and particularly relates to traditional Chinese medicine formula granules for treating children cough variant asthma and a preparation method thereof. The traditional Chinese medicine formula granules are prepared from the following raw materials: prepared herba ephedrae, cortex mori radicis, radix scutellariae, Japanese ardisia herb, semen lepidii, aster tataricus, flos farfarae, fructus perillae, lumbricus, radix platycodonis, bombyx batryticatus, rhizoma pinellinae praeparata, semen armeniacae amarae, prepared liquorice root, pericarpium citri reticulatae, periostracum cicada and lactose. The traditional Chinese medicine formula granules for treating the children cough variant asthma are carefully developed according tothe traditional Chinese medicine formula and preparation principles, and effective components are extracted according to the modern extraction technology of traditional Chinese medicine, so that thetraditional Chinese medicine formula granules have the characteristics of strong pertinence, good curative effect, short period and no toxic and side effects.

The invention discloses applications of a traditional Chinese medicine composition in the preparation of a medicament for treating cough variant asthma. The medicament in the invention mainly comprises fructus forsythiae, honeysuckle, radix isatidis, Chinese rhubarb, patchouli, male fern rhizome, rhodiola root and the like. The medicament exerts the overall regulation advantage of the compound traditional Chinese medicine and organically combines the functions of dispelling diseases and evil, relieving symptoms and regulating immunity, thereby realizing the multi-target treatment. The clinicalexperiment verifies that the medicament has obvious curative effects on treating cough variant asthma.

The invention provides a traditional Chinese medicine for treating children cough variant asthma and a preparation method of the traditional Chinese medicine, and relates to the technical field of medicines. The traditional Chinese medicine for treating children cough variant asthma consists of the following raw materials: semen lepidii, radix scrophulariae, platycodon grandiflorum, rheum officinale, radix clematidis, scutellaria baicalensis, talc, caramel malt and fried rhizoma atractylodis. The medicine has a good curative effect on the children cough variant asthma, is fast and obvious in curative effect, does not have an adverse effect and can serve as a first-line drug for treating the children cough variant asthma.

The invention discloses traditional Chinese medicine granules for treating postinfectious cough and CVA (cough variant asthma) as well as a preparation method and an application of the traditional Chinese medicine granules. The traditional Chinese medicine granules comprise effective medicine components and pharmaceutically proper pharmaceutical excipients, wherein the traditional Chinese medicine raw materials for preparing the effective medicine components comprise 1-12 parts by weight of mix-fried ephedra, 1-12 parts by weight of perilla leaf, 1-12 parts by weight of earthworm, 1-12 parts by weight of prepared loquat leaf, 1-8 parts by weight of perilla fruit, 1-10 parts by weight of cicada slough, 1-10 parts by weight of hogfennel root, 1-12 parts by weight of great burdock achene and 1-10 parts by weight of Chinese magnoliavine fruit; the pharmaceutically proper pharmaceutical excipients comprise beta-cyclodextrin, mannitol, sodium carboxymethyl starch and dextrin.

The invention discloses a medicine for treating cough variant asthma. The medicine comprises 8-12 parts of momordica grosvenori, 4-8 parts of radix polygonati officinalis, 9-15 parts of radix astragali preparata, 3-7 parts of indigo naturalis, 4-8 parts of blackberry lily, 4-8 parts of rhizoma pinellinae praeparata, 4-8 parts of radix stemonae, 6-12 parts of tussilago farfara, 4-8 parts of aster,0.8-1.2 parts of as arum, 8-12 parts of earthworm, 7-11 parts of radices stellariae dichotomae, 8-12 parts of smoked plum, 4-8 parts of radix saposhnikoviae, 8-12 parts of schisandra chinensis, 4-8 parts of radix pseudostellariae, 13-17 parts of rhizoma phragmitis and 13-17 parts of cogongrass rhizome; the medicine is beneficial to improving immunity, clearing heat, removing toxicity, clearing throats, relieving a cough, resisting allergic and preventing recurrence, has good medicine flavor, and is convenient to drink. In a word, the formula is reasonable in compatibility of medicines and is an effective prescription for taking temporary solution and effecting a permanent cure as well as treating both principal and secondary aspects of cough variant asthma. Tests show that the effective rate is up to 96.7%, no dependency or rebound phenomenon caused by drug withdrawal are generated, the medicine not only can tonify the lung and benefit qi as well as relieve a cough and asthma, but also can resist allergy and prevent recurrence, and compared with therapy by western medicines, the medicine provided by the invention has certain advantages.

The invention provides a pharmaceutical composition for treating cough variant asthma. The pharmaceutical composition is prepared from, by weight, 6-20 parts of radix aconiti carmichaeli, 3-12 parts of honey-fried herba ephedrae and 3-12 parts of licorice roots. The pharmaceutical composition has the effects of relieving asthma, relaxing tracheal smooth muscles and reducing the leukotriene content of lung tissue. According to long-term observation, when the pharmaceutical composition is used for treating the cough variant asthma, the cough symptom can be rapidly removed, the cure rate is high, both symptoms and root causes are treated, and the cough variant asthma does not relapse after being cured.

The invention relates to a naringin drug composition for relieving cough, eliminating phlegm and relieving asthma and a preparation thereof. The naringin drug composition is characterized in that the naringin drug composition contains naringin and fexofenadine hydrochloride, the content per unit of the naringin in each compounding agent (preparation) is 27.5-275 mg, and the content per unit of the fexofenadine hydrochloride is 30-300 mg; in the composition, the preferred mass ratio of the naringin to the fexofenadine hydrochloride is 1 to 1, and the preferred dosage of the naringin and the fexofenadine hydrochloride in each compounding agent (preparation) are 40 mg and 40 mg respectively. The naringin drug composition and the preparation thereof have the benefits that with the adoption of the drug composition, the cough and the phlegm caused by various reasons as well as the cough variant asthma can be treated; the drug composition can be added with conventional excipients and then can be prepared into a drug for relieving cough, eliminating phlegm and relieving asthma by adopting any conventional methods; the drug effect generated by the composition is better than that generated when the naringin or the fexofenadine hydrochloride is independently used.

The invention discloses a traditional Chinese medicine mixture for treating asthma. The traditional Chinese medicine formula comprises the following ingredients: Group A: 10-18 g of balloonflower root, 10-15 g of stemona, 6-15 g of catnip, 6-12 g of radix asteris, 4-12 g of dried orange peel, 6-12 g of radix bupleuri, 6-15 g of root of large-flowered skullcap, 8-20 g of rhizoma pinelliae preparata, 10-25 g of Chinese angelica, 10-20 g of white peony root, 18-25 g of cicada slough, 20-35 g of roasted folium eriobotryae, 10-15 g of spine date seed, 8-15 g of polygala root and 5-12 g of licorice; and Group B: 5 g of cordyceps sinensis, 8 g of pseudo-ginseng, 4 g of Mythic Fungus, 6 g of honey, 6 g of rock sugar and one pear. The traditional Chinese medicine mixture for treating asthma has characteristics as follows: good therapy for asthma; easily-available medicinal materials; simple preparation; low cost; no toxic or side effect; and good treatment effect.

The invention provides traditional Chinese medicine tablets for treating a postinfectious cough and a cough variant asthma, and a preparation method and application thereof. The traditional Chinese medicine tablets comprise medicine effective ingredients and medicinal auxiliary materials applicable to pharmacy. The effective ingredients are prepared from, by weight, 4-6 parts of roasted ephedra, 4-6 parts of perilla leaves, 4-6 parts of lumbricus, 4-6 parts of roasted folium eriobotryae, 2-4 parts of perillaseeds, 3-5 parts of periostracum cicada, 3-5 parts of common hogfenneI roots, 4-6 parts of burdock and 3-5 parts of the fruits of Chinese magnoliavine. The medicinal auxiliary materials applicable to pharmacy comprise microcrystalline cellulose, corn starch, pearlitol and micropowder silica gel.

The invention relates to a traditional Chinese medicine composition for treating cough variant asthma in children. The traditional Chinese medicine composition is capable of solving the problem of medication use in face of cough variant asthma in children effectively. The technical scheme includes that the traditional Chinese medicine composition is prepared from, by weight, 2-6 parts of herba ephedra, 2-6 parts of bitter apricot seeds, 3-12 parts of radish seeds, 2-10 parts of concretio silicea bambusae, 1-3 parts of agilawood, 2-6 parts of inula flowers, 1-6 parts of bombyx batryticatus, 1-5 parts of nidus vespae, 2-6 parts of giant typhonium rhizomes and 3-10 parts of butterflybush flowers. The traditional Chinese medicine composition is capable of ventilating the stagnated lung qi to relieve a cough, reducing phlegm, depressing qi, dispelling wind and relieving spasm and can improve clinical symptoms of children suffering from the cough variant asthma effectively, thereby being a pharmaceutical innovation for treating the cough variant asthma in children.

A naringin composition and preparations thereof are provided. The pharmaceutical composition comprises naringin and levocetirizine hydrochloride, and preferably, 27.5-275 mg of naringin and 1.25-12.5 mg of levocetirizine hydrochloride, where the preferred weight ratio of naringin to levocetirizine hydrochloride is 20:1. The pharmaceutical composition has good curative effects on cough and sputum production originating from various causes and on cough variant asthma. The efficacy of the pharmaceutical composition is obviously superior to that of naringin or levocetirizine hydrochloride that is used alone.

The Chinese medicinal composition for treating cough after cold and cough variant asthma consists of effective component prepared with Chinese ephedra, leaf of purple perilla, seed of purple perilla, earthworm, etc. and pharmaceutically acceptable carrier. It may be prepared into any preparation form. The Chinese medicinal composition has obvious effects of relieving cough, resisting inflammation, relieving asthma, eliminating phlegm, immunizing, etc. and can raise the reaction threshold and Dmin of respiratory tract on acetyl methyl choline and lower sGrs and EOS, ECP and IL-5 of peripheral blood. The present invention also relates to the preparation process of the Chinese medicinal composition.

The invention discloses a traditional Chinese medicine composition for treating cough variant asthma. The traditional Chinese medicine composition is prepared from the following active pharmaceutical ingredients: arrowleaf abelmoschus root, hylocereus undwithus flowers, greenish lily flowers, talinum crassifolium, mahonia bealei carr, dogwood, parnassia palustris, momordica grosvenori, ceylon helminthostachys rhizome and paederia scandens. The traditional Chinese medicine composition for treating the cough variant asthma provided by the invention has the advantages of remarkable curative effect, no side effects, high compliance of patients and the like; the traditional Chinese medicine composition decoction for treating the cough variant asthma provided by the invention is adopted for treating 34 patients four weeks; among the 34 patients, 9 patients are clinically cured, 13 patients are cured with obvious effect, 9 patients are cured effectively, 3 patients are not cured; the total effective rate is 91.2%.

The invention relates to a traditional Chinese medicine composition for curing cough variant asthma, and can effectively solve the problem of difficulty in use of medicines of cough variant asthma. The technical scheme to solve the problem is that the composition is prepared from the following raw medicines in parts by weight: 2 to 6 parts of Chinese ephedra, 2 to 6 parts of almond, 3 to 12 parts of muskroot-like semiaquilegia herb, 2 to 10 parts of semen oroxyli, 1 to 3 parts of bryozoatum, 2 to 6 parts of inula flower, 5 to 20 parts of angelica sinensis, 5 to 15 parts of the root of red-rooted salvia, 3 to 10 parts of gecko and 3 to 10 parts of placenta hominis. The composition provided by the invention has the efficacies of ventilating lung and resolving phlegm, promoting blood circulation to remove blood stasis, and invigorating lung and kidney, can effectively improve clinical symptoms of cough variant asthma patients, and is an innovation on a medicine for curing cough variant asthma.

The invention relates to naringin composition and a preparation thereof. The pharmaceutical composition is characterized by comprising naringin and levocetirizine hydrochloride, wherein preferably, the naringin is in a range of 27.5-275 mg, and the levocetirizine hydrochloride is in a range of 1.25-12.5 mg; the preferable mass ratio of the naringin to the levocetirizine hydrochloride is 20:1. Tests prove that the pharmaceutical composition has good curative effects on coughs and excessive phlegm caused by various reasons and the cough variant asthma, and the efficacy of the composition is obviously superior to the efficacy of the independently-used naringin or the independently-used levocetirizine hydrochloride.

The invention discloses a wind-dispersing and couch-relieving traditional Chinese medicine composition which is prepared from the following ingredients in parts by weight: 6-10 parts of radix bupleuri, 6-10 parts of scutellaria baicalensis, 6-10 parts of schizonepeta, 6-10 parts of radix sileris, 6-10 parts of sweet flos farfarae, 6-9 parts of parched bitter almond, 10-15 parts of parched white peony root, 6-10 parts of dark plum fruits, 10-15 parts of rhizoma dioscoreae nipponicae, 10-15 parts of polygonum cuspidatum, 6-10 parts of rhizoma belamcandae and 3-6 parts of raw liquorice. The traditional Chinese medicine composition has the effects of dispersing wind and releasing lungs, relieving a cough and reducing sputum and getting spasmolysis and calming down asthma, especially has an obvious treatment effect in treating cough variant asthma and is targeted; and the diseases are not easy to occur repeatedly after being cured.

The invention discloses a preparation method of a cough suppressing essence. The method comprises the following steps of: (1) weighing raw materials according to weight, mixing and grinding into a fine powder; (2) then decocting the powder, and concentrating the soup; and (3) filtering the solution obtained in the step (2) to obtain the cough suppressing essence. The invention has the following advantages: 1. excellent effects on cough variation asthma, upper airway syndrome, chronic bronchitis and chronic cough sputum syndrome after upper respiratory tract infection; 2, easiness to use, accordance with people's medication habits, and easy acceptance by the majority of patients; 3, low price and alleviation of the problem of expensive drug; 4, usage safety and no toxic or side effect; and 5, simple operation.

The invention relates to a traditional Chinese medicine composition for treating cough, made from 3-15 parts of mulberry silkworm, 3-15 parts of cicada slough, 5-15 parts of roasted herb of Chinese ephedra, 5-15 parts of apricot seed, 5-15 parts of roasted loquat leaf, 5-15 parts of roasted root of sessile stemona, and the like. The traditional Chinese medicine composition can effectively treat cough due to various causes, has light side effects, and can effectively treat, particularly, cough variant asthma, acute bronchitis, and gastro-esophageal reflux induced cough.

The invention discloses a Chinese herb preparation for treating the cough variant asthma. The Chinese herb preparation comprises the raw material herbs of embelia parviflora, bicolor limonium, choerospondias axillaries, straw nutgrass galingale rhizome, radix curcumae, balloon flowers, uncaria roots, honeysuckle stems, passion flowers, stiff silkworms, lindley eupatorium herbs and pearl viburnum fruits. The Chinese herb preparation for treating the cough variant asthma has the advantages of having a remarkable treatment effect, being free of side effects, making a patient have good compliance and the like. The Chinese herb preparation for treating the cough variant asthma is decocted with water to treat 36 patients for four weeks, the result shows that 10 patients are cured through clinical treatment, and the preparation shows an effect on 13 patients and is effective for 9 patients and ineffective for 4 patients, and therefore the total effective rate is 88.9%.

The invention belongs to the field of Chinese patent medicines, and discloses a Chinese patent medicine for treating spleen and lung qi deficiency type cough variant asthma (CVA) of children and a preparation method of the Chinese patent medicine. The following medicinal materials required to prepare per hundred grams of the Chinese patent medicine: 9-21 g of radix pseudostellariae, 19-31 g of rhizoma dioscoreae, 19-31 g of rhizoma atractylodis macrocephalae, 19-31 g of lotus seed, 19-31 g of fried white hyacinth beans, 19-31 g of platycodon root, 19-31 g of poria, 19-31 g of stir-baked radishseed, 9-21 g of inner membrane of chicken gizzard, 19-31 g of semen mangiferae indicae, 19-31 g of hawthorn fruit, 19-31 g of coix seed, 35-65 g of millet sprout, 35-65 g of malt, 35-65 g of immaturewheat, 19-31 g of prepared liquorice root, 3-8 g of villous amomum fruit, 19-31 g of fructus forsythiae, 9-21 g of steamed tangerine peel, 9-21 g of honey, and 9-21 g of maltose. The Chinese patent medicine is used for treating the children in a spleen and lung qi deficiency type CVA remission stage, and can effectively improve the cellular and humoral immune function of the children, improve theoverall treatment effect of the disease, and improve the cellular and humoral immune function of the children, thereby greatly reducing the treatment time.

The invention relates to an application method of a soft capsule containing sheep placenta, radix salviae miltiorrhizae and grape seeds, namely, an application of the soft capsule containing sheep placenta, radix salviae miltiorrhizae and grape seeds in preparing a cough medicine, and specifically, sheep placenta freeze-dried powder, grape seed extract, radix salviae miltiorrhizae extract, soybean oil, beewax, gelatin and glycerinum are adopted as raw materials, and subjected to the main procedures including smashing, mixing, homogenizing, pelleting, drying and the like to prepare the cough medicine. The cough medicine prepared by the soft capsule containing sheep placenta, radix salviae miltiorrhizae and grape seeds is significant in cough relieving effect, and has an obvious effect in alleviating the cough symptom of the cough variant asthma.

The present invention is directed to compounds or pharmaceutically acceptable salts thereof for use in the treatment of cough, in particular idiopathic chronic cough, cough variant asthma, cough associated with thoracic tumour or lung cancer, viral and post-viral cough, upper airways cough syndrome (UACS) or post nasal drip cough, and cough associated with disorders such as gastro oesophageal reflux disease (both acid and non acid reflux), chronic bronchitis, chronic obstructive pulmonary disease (COPD), interstitial lung disease (such as idiopathic pulmonary fibrosis (IPF)), congestive heart disease, sarcoidosis and infection (such as whooping cough.

The invention relates to a traditional Chinese medicine syrup for treating infantile cough variant asthma. The traditional Chinese medicine syrup is prepared from, by weight (according to the dose of1000ml), 5-80 grams of fried intermediate ephedra herbs, 5-80 grams of blackberrylily rhizomes, 5-100 grams of sessile stemona roots, 5-100 grams of apricot seeds, 10-100 grams of Chinese arborvitae branchlet tips and leaves, 5-100 grams of bal loonflower roots, 10-150 grams of reed rhizomes, 5-80 grams of ural licorice roots, 10-100 grams of Mongolian snakegourd fruits, 10-100 grams of Ussuri fritillary bulb, 5-80 grams of ginkgo seeds, 5-80 grams of pepperweed seeds, 5-80 grams of British inula flowers, 5-100 grams of fried common perilla fruits, 5-80 grams of loquat leaves and 10-100 gramsof common hogfennel roots. The traditional Chinese medicine syrup for treating the infantile cough variant asthma has the functions of ventilating lung, eliminating phlegm, relieving cough and relieving asthma, can effectively improve clinical symptoms of an infantile cough variant asthma patient and is innovated on medicines for treating the infantile cough variant asthma.

The invention relates to a traditional Chinese medicine composition for treating cough. The raw materials include 3-15 parts of silkworms, 3-15 parts of cicada sloughs, 5-15 parts of roasted ephedra, 5-15 parts of almonds, 5-15 parts of sun-baked papaya leaves and sun-baked 5‑15 copies of 100 parts, etc. The traditional Chinese medicine composition has good therapeutic effect on coughs caused by various reasons and has mild side effects. Especially for the treatment of cough variant asthma, acute bronchitis and gastroesophageal reflux cough have a better effect.

The invention discloses a Chinese herbal decoction for treating liver-fire attacking lung type cough variant asthma. The Chinese herbal decoction is prepared from the following traditional Chinese medicinal materials by weight: 8 parts of the herb of Pleurospermum lindleyanum, 8 parts of pine resin, 8 parts of the cauloid of Dendrobium aphyllum, 7 parts of the leaf of Cassia siamea, 6 parts of common alstonia leaves, 5 parts of beet roots, 5 parts of Herba Epimedii, 6 parts of the herb of Asclepias curassavica, 8 parts of scoliid honeycomb, 6 parts of the dried roots and stems of Heteropanax fragrans, 6 parts of the fruit or seed of pistachio, 6 parts of the herb of Dregea sinensis, 5 parts of Chinese ilex leaves, 5 parts of licorice roots, 6 parts of the cauloid of Dendrobium aphyllum, 6parts of Poria cocos, 6 parts of the dried tuber of Pinellia ternate, 6 parts of dried orange peel, 6 parts of pseudostellaria root, 6 parts of Radix Asparagi, 6 parts of apricot kernels, 6 parts of Radix Scutellariae, 6 parts of the root of Lobelia pleotricha Diels and 6 parts of mulberry bark. Clinical experiments prove that through reasonable combination of the traditional Chinese medicinal materials, the prepared Chinese herbal decoction is beneficial for treatment of liver-fire attacking lung type cough variant asthma, can effectively reduce recurrence of liver-fire attacking lung type cough variant asthma and achieves integral adjusting and long-term treatment effects.

The invention discloses a traditional Chinese medicine decoction capable of treating cough variant asthma. The traditional Chinese medicine decoction is prepared from the following raw materials in parts by weight: 15 to 20 parts of fructus siraitiae, 6 to 10 parts of folium isatidis, 8 to 10 parts of apricot kernel, 10 to 15 parts of ginger slices, 5 to 10 parts of sesame seeds, 10 to 15 parts of common sage herb, 8 to 12 parts of scrambled egg shell, 5 to 6 parts of peach kernel, 2 to 4 parts of rhodiola rosea, 6 to 8 parts of pinelliae rhizome praeparatum cum zingibere et alumine, 2 to 4 parts of chamomile, 6 to 8 parts of arisaema cum bile, 4 to 5 parts of false indigo herb, 6 to 8 parts of false aloe, 2 to 4 parts of spina Chinese honeylocust fruit, 6 to 10 parts of roasted Chinese ephedra herb, 2 to 3 parts of scouring rush, 6 to 8 parts of prepared rhizoma cyperi, 4 to 5 parts of dried radish, 1 to 3 parts of auriculateleaf aster and 2 to 4 parts of schoenoplectus mucronatus. The traditional Chinese medicine decoction utilizes traditional Chinese medicines as raw materials and is capable of fundamentally curing cough variant asthma by combining the comprehensive effects of various traditional Chinese medicines; by virtue of the synergistic effect of various medicaments, the curative effect of drug therapy is improved, and the traditional Chinese medicine decoction achieves the effects of clearing away heat and toxic materials, replenishing qi and essence, eliminating dampness to reduce phlegm and nourishing the kidney and moistening the lung, thereby achieving the purpose of treating cough variant asthma.

The invention provides application of a compound Haqing injection in preparing a drug for treating diseases of a respiratory system. The drug is formed by the compound Haqing injection and one or a combination of Ruyi anti-asthma pills and lidocaine. The drug is used for acupoint injection to treat one or multiple diseases of a cold, acute and chronic bronchitis, a chronic obstructive pulmonary disease, emphysema, a pulmonary heart disease, asthmatic bronchitis, bronchopneumonia, interstitial pneumonia and cough variant asthma. It is proved through experimental results of clinical cases that the drug for acupoint injection is significant in curative effect on the diseases of the respiratory system and particularly obvious in curative effect on the diseases such as the chronic obstructive pulmonary disease and cough variant asthma.